Evidence map›Paper›PMID 32426360›Full record

ReviewFrontiers in medicine2020

Autoinflammatory Mechanisms in Crystal-Induced Arthritis.

Francesca Oliviero, Sara Bindoli, Anna Scanu, Eugen Feist, Andrea Doria, Paola Galozzi, Paolo Sfriso

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Autoinflammatory Features in Gouty Arthritis.Journal of clinical medicine · 2021
    Review
  15. Article
  16. Article
  17. Imaging of Joints and Bones in Autoinflammation.Journal of clinical medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Francesca OlivieroRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Sara BindoliRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Anna ScanuRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Eugen FeistDepartment of Rheumatology, Cooperation Partner of the Otto-von-Guericke, University Magdeburg, Helios Clinic, Vogelsang-Gommern, Germany.
Andrea DoriaRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Paola GalozziRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Paolo SfrisoRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
University of Padua · ITOtto-von-Guericke University Magdeburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crystal-induced arthritides have been classified as "type-1 autoinflammatory diseases" for their main features which resemble those of the monogenic autoinflammatory syndromes. They are in fact characterized by spontaneous onset, recurrence of the episodes, self-limitation and resolution, inflammasome activation with huge production of IL-1β and a prevalent involvement of the innate immune system. The term "auto" refers also to the induction of IL-1β gene expression, processing and secretion by IL-1β itself. The concept of autoinflammation in crystal-induced arthritis has been finally reinforced by the efficacy of IL-1 blockade in treating acute and chronic state of this disease. The aim of this article is to review the autoinflammatory mechanisms in crystal-induced arthritis, considering both clinical and molecular aspects.

Indexed as

autoinflammatory diseasecrystal-induced arthritisinflammasomeinterleukin-1interleukin-1 receptor antagonist

Identifiers

PMID32426360
PMCPMC7203538
OpenAlexW3022260343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.